News Archives | Page 18 of 20 | UNC Blood Research Center

The Oncologist “D-dimer enhances risk targeted thromboprophylaxis in ambulatory cancer patients” Background: Thromboprophylaxis for ambulatory cancer patients is effective, although uncertainties remain on who should be targeted. using D-dimer values from individuals enrolled to the AVERT trial, we sought to identify and validate a more efficient VTE risk threshold for thromboprophylaxis. Read Publication here

Congratulations to Nigel Mackman on receiving the ATVB Highly Cited Award! As a member of the Editorial Board who publish their high level science in ATVB, we will be recognizing the publication by Editorial Board members that were the most highly cited in the determination of the 2019 impact factor. Manuscript: Tissue Factor: An Essential …

What is myocarditis? How is it linked to COVID-19? And why is it a concern for athletes? Dr. Silvio Antoniak explains- One of the more concerning side effects of COVID-19 infection is myocarditis — a once rare condition of inflammation of the heart, leading to scar tissue build-up and a weakening of the heart. A …

Congratulations to Jean Marie Mwiza, a graduate research assistant in the Bergmeier and Wolberg Labs, for recently receiving an F31 research fellowship award from NIH’s NHLBI. Jean Marie’s fellowship provides ongoing stipend support, beginning January, 2021, for his project, titled “Determining the Platelet Signaling Pathway(s) Critical in Venous Thrombosis Pathogenesis”.

Silvio Antoniak, PhD, assistant professor in the UNC Department of Pathology and Laboratory Medicine and member of the UNC Blood Research Center and the UNC McAllister Heart Institute, was awarded a four-year, $2.2 million grant from the NIH-NHLBI to investigate the potential therapeutic approach in inhibiting PAR1 to treat chemotherapy-induced heart failure.

Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Publication Lori A. Holle, Dougald M. Monroe and Alisa S. Wolberg VWF (von Willebrand Factor) Is Not Required for Red Blood Cell Retention in Clots in Mice View publication

Congratulations- R01 awarded to Dr. Maria Aleman (PI), R01 was awarded on a $2 million (direct costs only) 5-year R01 grant; funding period (2020-2025). Scientific team includes outstanding scientists and collaborators, Co-Investigators Dr. Raj Kasthuri and Dr. Daniel Dominguez (not pictured). Institute: NIH/NIDDK (1R01DK124773-01) Title: Iron-sensitive RNA regulation during erythropoiesis PI: Maria Aleman PhD (Pharmacology); …

International Society on Thrombosis and Haemostasis The results have been tallied in the runoff election for the Society’s next Secretary General. Nigel Key has secured the majority of votes, and will serve in the role for the 2020-2023 term. Congratulations Dr. Key! ISTH Website

“Given his interest and engagement in space travel and risk of thrombosis (we reported here: Link to article, UNC Department of Medicine, Dr. Moll has been invited to give a presentation at the upcoming meeting of the American Institute of Aeronautics and Astronautics (AIAA) in Nov 2020 entitled “The Potential of Telepresence to Transform Future …

Dr. Stephan Moll, UNC Hematology and member of the UNC Blood Research Center published a clinical educational article last week entitled “How I Treat: Unexplained Arterial Thromboembolism”, following an invitation by the Blood Journal of the American Society of Hematology. The article nicely bridges hematology, vascular medicine, neurology, cardiology and general medicine, discussing the existing …

UNC Blood Research Center member Dougald Monroe is a coauthor along with Maureane Hoffman on a commentary published in Blood. The commentary, EPCR knockout: inflaming the discussion, provides context for the Blood article from the group of Vijay Rao on how reduced EPCR function protects against joint bleeding-induced pathology in hemophilia mice. The commentary discusses …

SOM / NCTraCS ECBR pilot grant application titled “Measurement of plasma biomarkers to determine the mechanism of the coagulopathy in COVID-19 patients” Funding in the amount of $50,000 will be provided jointly by the School of Medicine and NCTraCS and is for a 12-month period.

Category: News

Vaibhav Kumar MD, Hematology-Oncology fellow, publishes study defining improved thresholds for thrombosis prophylaxis in cancer in the ‘The Oncologist’”

ATVB Highly Cited Award to Nigel Mackman, PhD and Steven Grover, PhD

What is myocarditis? Silvio Antoniak, PhD featured research news from UNCs ‘the WELL’

Jean Marie Mwiza, Receives F31 Research Fellowship Award from NIH-NHLBI

Dr. Silvio Antoniak awarded $2.2 million grant from NIH-NHLBI

ATVB Publication: VWF (von Willebrand Factor) Is Not Required for Red Blood Cell Retention in Clots in Mice

R01 awarded to Dr. Maria Aleman (PI), Dr. Raj Kasthuri and Dr. Daniel Dominguez (Co-Is) Title: Iron-sensitive RNA regulation during erythropoiesis

Congratulations to Dr. Nigel Key Elected ISTH Secretary General- 2020-2023 International Society on Thrombosis and Haemostasis

The Ultimate Telemedicine: Stephan Moll Helps Treat Astronaut’s Blood Clot During NASA Mission

Dr. Stephan Moll, Blood Journal of ASH published: “How I Treat: Unexplained Arterial Thromboembolism”

UNC Blood Research Center member Dougald Monroe is a coauthor along with Maureane Hoffman on a commentary published in Blood.

SOM/NCTraCS ECBR Pilot Grant Funded! Dr. Nigel Key and Dr. Nigel Mackman